United Therapeutics Corp files 8-K regarding executive and director changes

United Therapeutics Corp has filed an 8-K disclosing changes to its board of directors or executive officers, alongside compensatory arrangements. The filing indicates internal corporate governance adjustments, though specific details on the individuals involved or the nature of the departures remain to be extracted from the full exhibit.